Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke Patients with History of Prior Stroke Plus Diabetes

BACKGROUND AND PURPOSE: Acute ischemic stroke (AIS) patients with history of prior ischemic stroke plus concomitant diabetes mellitus (DM) were excluded from the ECASS III trial due to safety concerns. However, there are few data on use of intravenous tissue plasminogen activator (tPA) and symptomat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stroke
Main Authors: Ehrlich, Matthew E., Liang, Li, Xu, Haolin, Kosinski, Andrzej S., Hernandez, Adrian F., Schwamm, Lee H., Smith, Eric E., Fonarow, Gregg C., Bhatt, Deepak L., Peterson, Eric D., Xian, Ying
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6538420/
https://ncbi.nlm.nih.gov/pubmed/31035901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.118.024172
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados